DSDM Pharma SRL
DSDM Pharma reported total assets of €1.64m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of DSDM Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +19 % Total assets +62 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DSDM Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 211,084 € | ||||
| Equity | 635,891 € | ||||
| Cash | 30,149 € | ||||
| EBITDA | 371,698 € | ||||
| Total assets | €1.64m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 23 Oct 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
DSDM Pharma's financial analysis
- Solvency38.7%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DSDM Pharma
DSDM Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0894.719.585
- VAT number
- BE0894719585
- Peppol
- Registered · 0208:0894719585 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jan 2008
- Registered office
- 9031 Ghent
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
DSDM Pharma (SRL) has been based in Ghent since 2008, active in: business and other management consultancy activities. For 2025, it reports a net profit of 211,084 € and equity of 635,891 €; its revenue is not published. Its solvency stands at 38.7%, below the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DSDM Pharma
Companies in the same business, of comparable size and area, outside its group.
- Axis Capital Business and other management consultancy activities Antwerp · balance sheet €1.63m
- Koala Invest Business and other management consultancy activities Mons · balance sheet €1.90m
- Lumocom Business and other management consultancy activities Kortrijk · balance sheet €1.62m
- Steman Business and other management consultancy activities Stekene · balance sheet €1.67m
- EXL Management Services Business and other management consultancy activities Staden · balance sheet €1.67m
- Baer Castle International Business and other management consultancy activities Grobbendonk · balance sheet €1.60m
- Disana Business and other management consultancy activities Alken · balance sheet €1.59m
- Ooms Projects Business and other management consultancy activities Wuustwezel · balance sheet €1.59m
Frequently asked questions about DSDM Pharma
What is the revenue of DSDM Pharma?
DSDM Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DSDM Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0894719585 for DSDM Pharma, if the company is VAT-registered. Its company number (CBE) is 0894.719.585.
Where is the registered office of DSDM Pharma?
According to the CBE register, the registered office of DSDM Pharma is in 9031 Ghent.
What is the equity of DSDM Pharma?
At the close of the 2025 financial year, the equity of DSDM Pharma amounts to 635,891 €, a solvency of 38.7% of total assets.
Who manages DSDM Pharma?
The register lists 2 active mandates at DSDM Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DSDM Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →